Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Price indices track market movements to gauge overall levels. This intro explains what a price index is and why it matters for investors and analysts.
21,879 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A personal financial disclosure reveals Trump earned more than a billion dollars from crypto ventures last year, incl...
A deep dive into the hidden costs behind a record wealth year linked to branding, properties, and regulatory exposure...
Vietnam and the Philippines have been upgraded to upper-middle-income status, signaling a new growth phase and bringi...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...
When a public figure announces an engagement in a sun-kissed Santorini moment, questions about money, planning, and p...
AI’s power needs are lifting uranium miners into mainstream focus, aided by the URA ETF as nuclear energy gains renew...
Tesla faces a pivotal test as its stock trades near a multi-trillion dollar valuation. The company posted solid quart...
Strive disclosed a marked drop in fair value for Strategy’s STRC, signaling a bitcoin treasury’s paper loss that coul...
Morgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
Apple unveils a multiyear AI silicon plan, signaling a major shift toward in-house AI hardware. Our analysis maps a p...
Coinbase reports a resilient services business while MicroStrategy shoulders heavy bitcoin exposure and fixed costs a...